← Eichor
Condition: Upadacitinib Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Upadacitinib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Phase 1/Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06873100Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease
Phase 1 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06902987Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06095596An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With
Phase N/A · 104 location(s) · AbbVie · NCT06023030Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.
Phase N/A · 14 location(s) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT06630715A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Phase 3 · 138 location(s) · Takeda · NCT06227910A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupil
Phase 3 · 128 location(s) · AbbVie · NCT06389136Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（U
Phase 4 · 4 location(s) · Yongquan Shi · NCT07546097Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT06684522COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
Phase N/A · 4 location(s) · University of North Carolina, Chapel Hill · NCT07198113A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase N/A · 53 location(s) · AbbVie · NCT06712628TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response
Phase 4 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07510191Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in
Phase 4 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06520397An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Modera
Phase N/A · 38 location(s) · AbbVie · NCT06421740Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
Phase 4 · 4 location(s) · Xijing Hospital of Digestive Diseases · NCT07550673Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Even
Phase 3 · 47 location(s) · AbbVie · NCT05609630A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan W
Phase 3 · 15 location(s) · AbbVie · NCT07023302Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
Phase N/A · 6 location(s) · Xiang Gao · NCT06780683A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy
Phase 1 · 1 location(s) · AbbVie · NCT07425899A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · 285 location(s) · AbbVie · NCT05889182Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severel
Phase 3 · 85 location(s) · AbbVie · NCT06332534A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever
Phase 3 · 282 location(s) · AbbVie · NCT06012240Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease
Phase N/A · 7 location(s) · AbbVie · NCT06581042A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With C
Phase N/A · 25 location(s) · AbbVie · NCT07073079Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
Phase N/A · 3 location(s) · Universidade do Porto · NCT06498167Efficacy of Upadacitinib After NECS in Vitiligo
NA · 1 location(s) · Jilin University · NCT06454461A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Phase 4 · 5 location(s) · CARE ARTHRITIS LTD. · NCT06454188Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
Phase N/A · 1 location(s) · Technische Universität Dresden · NCT06937788BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
Phase N/A · 14 location(s) · UMC Utrecht · NCT03549416An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate
Phase N/A · 3 location(s) · AbbVie · NCT06838845
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.